Tumor budding correlates with discohesive growth pattern, tumor invasiveness and is associated with worse survival of pT1 Non-Muscle-Invasive Bladder Cancer (NMIBC)

被引：0
|
作者：
Eckstein, M. [1 ]
Kimmel, C. [2 ]
Bruendl, J. [2 ]
Weber, F. [3 ]
Denzinger, S. [2 ]
Gierth, M. [2 ]
Burger, M. [2 ]
Hartmann, A. [1 ]
Otto, W. [2 ]
Breyer, J. [2 ]
机构：
[1] Univ Erlangen Nurnberg, Dept Pathol, Erlangen, Germany
[2] Univ Regensburg, Dept Urol, Caritas St Josef Med Ctr, Regensburg, Germany
[3] Univ Regensburg, Dept Pathol, Regensburg, Germany
来源：
EUROPEAN UROLOGY | 2021年 / 79卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
P0448
引用
收藏
页码：S620 / S620
页数：1
相关论文
共 50 条
  • [1] Tumor budding correlates with tumor invasiveness and predicts worse survival in pT1 non-muscle-invasive bladder cancer
    Markus Eckstein
    Charlotte Kimmel
    Johannes Bruendl
    Florian Weber
    Stefan Denzinger
    Michael Gierth
    Maximilian Burger
    Arndt Hartmann
    Wolfgang Otto
    Johannes Breyer
    Scientific Reports, 11
  • [2] Tumor budding correlates with tumor invasiveness and predicts worse survival in pT1 non-muscle-invasive bladder cancer
    Eckstein, Markus
    Kimmel, Charlotte
    Bruendl, Johannes
    Weber, Florian
    Denzinger, Stefan
    Gierth, Michael
    Burger, Maximilian
    Hartmann, Arndt
    Otto, Wolfgang
    Breyer, Johannes
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [3] Loss of CHEK2 Predicts Progression in Stage pT1 Non-Muscle-Invasive Bladder Cancer (NMIBC)
    Spachmann, Philipp J.
    Azzolina, Vanessa
    Weber, Florian
    Evert, Matthias
    Eckstein, Markus
    Denzinger, Stefan
    Burger, Maximilian
    Otto, Wolfgang
    Breyer, Johannes
    PATHOLOGY & ONCOLOGY RESEARCH, 2020, 26 (03) : 1625 - 1632
  • [4] A novel grading approach predicts worse outcomes in stage pT1 non-muscle-invasive bladder cancer
    Haas, Maximilian
    Engelmann, Simon U.
    Mayr, Roman
    Gossler, Christopher
    Pickl, Christoph
    Kaelble, Sebastian
    Yang, Yushan
    Otto, Wolfgang
    Hartmann, Valerie
    Burger, Maximilian
    Hartmann, Arndt
    Breyer, Johannes
    Eckstein, Markus
    BJU INTERNATIONAL, 2024, 134 (02) : 249 - 257
  • [5] High PDL1 mRNA expression predicts better survival of stage pT1 non-muscle-invasive bladder cancer (NMIBC) patients
    Johannes Breyer
    Ralph M. Wirtz
    Wolfgang Otto
    Philipp Erben
    Thomas S. Worst
    Robert Stoehr
    Markus Eckstein
    Stefan Denzinger
    Maximilian Burger
    Arndt Hartmann
    Cancer Immunology, Immunotherapy, 2018, 67 : 403 - 412
  • [6] High PDL1 mRNA expression predicts better survival of stage pT1 non-muscle-invasive bladder cancer (NMIBC) patients
    Breyer, Johannes
    Wirtz, Ralph M.
    Otto, Wolfgang
    Erben, Philipp
    Worst, Thomas S.
    Stoehr, Robert
    Eckstein, Markus
    Denzinger, Stefan
    Burger, Maximilian
    Hartmann, Arndt
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2018, 67 (03) : 403 - 412
  • [7] DNA repair capacity and tumor recurrence in patients with non-muscle-invasive bladder cancer (NMIBC)
    Donahue, Timothy F.
    Donat, S. Machele
    Patel, Himali
    Chou, Joanne F.
    Bayuga, Sharon
    Olson, Sara H.
    Zerillo, Jessica Ann
    Dominguez, Gemma
    Leoce, Nicole M.
    Herr, Harry W.
    Orlow, Irene
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06)
  • [8] UHRF1 is associated with tumor recurrence in non-muscle-invasive bladder cancer
    Guo-Liang Yang
    Lian-Hua Zhang
    Juan-Jie Bo
    Hai-Ge Chen
    Ming Cao
    Dong-Ming Liu
    Yi-Ran Huang
    Medical Oncology, 2012, 29 : 842 - 847
  • [9] UHRF1 is associated with tumor recurrence in non-muscle-invasive bladder cancer
    Yang, Guo-Liang
    Zhang, Lian-Hua
    Bo, Juan-Jie
    Chen, Hai-Ge
    Cao, Ming
    Liu, Dong-Ming
    Huang, Yi-Ran
    MEDICAL ONCOLOGY, 2012, 29 (02) : 842 - 847
  • [10] Survival of non-muscle-invasive bladder cancer in Germany by tumor stage and grade
    Fiebig, J.
    Kraywinkel, K.
    Castro, F.
    Jansen, L.
    Zeissig, S. R.
    Luttmann, S.
    Katalinic, A.
    Holleczek, B.
    Brenner, H.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 88 - 88
12345